CongoMedicPlants · SAER Sarl · Democratic Republic of Congo
Operated by SAER Sarl and fully accredited by CODEP — the DRC's government-mandated Cannabis sativa regulatory authority — CongoMedicPlants cultivates 100% organic, pharmaceutical-grade medical cannabis for international export. Under the direct supervision of CODEP's national compliance framework, we deliver verified, export-ready product to licensed pharmaceutical buyers worldwide.
CongoMedicPlants, operated by SAER Sarl (Société Agropastorale et d'Énergie Renouvelable), is the Democratic Republic of Congo's foremost operational pharmaceutical cannabis production facility. As a founding accredited member of CODEP — the DRC's ministerially mandated regulatory authority — we produce Cannabis sativa of the highest pharmaceutical grade for licensed international buyers across multiple continents.
Our operation spans outdoor field cultivation, greenhouse-controlled environments, and indoor growing facilities — delivering a year-round production calendar of four complete harvest cycles annually. Every stage of production is conducted under CODEP's rigorous compliance supervision, with full chain-of-custody documentation, third-party laboratory testing, and compliance with international narcotics control treaty requirements coordinated through CODEP's relationship with the UN INCB in Vienna.
The farm's leadership combines doctoral-level agricultural science with deep operational expertise, directing a multidisciplinary workforce of agronomists, compliance officers, security personnel, logistics coordinators, and field technicians — all trained to pharmaceutical-industry standards.
As a fully accredited CODEP member producer, CongoMedicPlants operates under the entire suite of licences, certifications, and international compliance instruments held by CODEP Sarl. These are not aspirational targets — they are active, state-issued instruments that govern every gram we produce and every export shipment we despatch.
Arrêté Ministériel N°1250/CAB/MIN/SPHP/2023 grants CODEP Sarl — and all accredited member producers including CongoMedicPlants — the right to cultivate, produce, hold, commercialise, and export Cannabis sativa for medical and scientific purposes. Valid five years, renewable.
CODEP coordinates directly with the International Narcotics Control Board (INCB) — the UN's quasi-judicial expert body — ensuring all DRC Cannabis sativa exports, including those of CongoMedicPlants, comply fully with international narcotics control treaty obligations.
Official import-export registration enabling CODEP and all accredited member producers, including CongoMedicPlants, to conduct international trade operations. Issued under Ordonnance-Loi n°73-009, renewed annually.
Certifies 5,000 Cherry Blossom Hemp Seeds (Cannabis sativa) as quarantine-pest free, meeting DRC phytosanitary requirements. Confirms legitimate seed import from Blue Forest Farms LLC, Colorado — the genetics foundation of the CongoMedicPlants cultivar portfolio.
Third-party HPLC analysis of Cherry Blossom strain: CBDA 14.864%, CBD 1.699%, Max Active THC 0.30% (internationally compliant), Total Cannabinoids 18.22%. Confirms pharmaceutical-grade chemical profile meeting EU, Canadian, and Australian import specifications.
CODEP holds an active engagement with Maribec Health Products Inc., a Health Canada-licensed cultivation partner. This partnership provides CongoMedicPlants with access to Canadian regulatory expertise, genetic material, and quality assurance protocols aligned with one of the world's most rigorous pharmaceutical cannabis frameworks.
All CongoMedicPlants production is subject to technical pharmaceutical evaluation and oversight by ACOREP — the DRC's national pharmaceutical regulatory agency — as part of CODEP's ongoing compliance framework. ACOREP's role includes licence renewal assessment and product quality verification.
CODEP — and all member producers including CongoMedicPlants — operate under the oversight of the DRC's national intelligence and financial compliance authority (ANR). This layer of national security oversight ensures that all financial flows and operational activities meet the highest state-level security standards.
CongoMedicPlants operates full-cycle production across outdoor fields, greenhouse complexes, and indoor controlled environments — active across all four annual harvest cycles.
Hillside Field Cultivation: Outdoor field operations across CongoMedicPlants' hillside cultivation zones. Staff visible working active plant rows under full production conditions — one of four annual harvest cycles.
Greenhouse Operations Complex: Interior of CongoMedicPlants' climate-controlled greenhouse facility. Mature Cannabis sativa plants at peak canopy development, maintained under pharmaceutical-grade growing protocols.
Indoor Controlled Environment: Agronomist conducting plant inspection inside the greenhouse. All growing conditions — humidity, temperature, light — are continuously monitored and recorded for compliance documentation.
Trained Agronomic Technicians: Field technician performing hands-on plant inspection at harvest readiness stage. All staff operate under CODEP-supervised training protocols with full personal protective equipment.
Seedling Nursery — Controlled Propagation: Seedling and vegetative propagation zone. All genetics sourced from USDA-certified, HPLC-tested seed stock originating from Blue Forest Farms LLC, Colorado — verified THC-compliant.
Harvest — Quarterly Cycle: Active harvest operations in the outdoor cultivation fields. CongoMedicPlants operates four complete harvest cycles per year, ensuring year-round, uninterrupted supply to contracted buyers.
Pharmaceutical-Grade Dried Flower: Post-harvest drying racks inside temperature-controlled curing facility. All dried biomass is batch-numbered, weighed, and held under inventory lock pending third-party laboratory release.
Export-Ready Packaging & Batch Labelling: Packaging line operator processing export-ready pouches on the CongoMedicPlants labelling and sealing conveyor. Each batch is fully documented with lot number, cannabinoid profile, and compliance reference.
Quality Control — Pre-Export Inspection: QC team in full pharmaceutical PPE (lab coat, mask, gloves) inspecting bulk biomass against specification before export clearance. Inspection records accompany every outbound consignment to CODEP.
Logistics & Export Despatch: Warehouse and despatch zone with palletised, shrink-wrapped export consignments ready for collection. All outbound shipments are released only after CODEP export documentation is confirmed complete.
Security is not a peripheral function at CongoMedicPlants — it is a core compliance requirement. As a CODEP-accredited producer of controlled pharmaceutical substances, the farm operates under a multi-layered security framework that satisfies both DRC national security standards and the requirements of international pharmaceutical regulatory bodies.
Oversight is provided at the national level through the DRC's Economic and Financial Intelligence Department (ANR) — which monitors all CODEP-affiliated operations — and at the institutional level through CODEP's own compliance and audit function. This dual-layer oversight structure provides international buyers and investors with the assurance that CongoMedicPlants operates within a security envelope that meets the strictest available standards.
CongoMedicPlants cultivates a portfolio of CODEP-accredited cultivars — every variety individually approved under the DRC Ministerial Licence and backed by full USDA phytosanitary certification, third-party HPLC laboratory testing, and INCB treaty compliance documentation.
Every seed variety cultivated at CongoMedicPlants has been individually reviewed, approved, and accredited by CODEP Sarl under Ministerial Order N°1250/CAB/MIN/SPHP/2023. Seed importation, planting material, seeding approval, and cultivation supervision are coordinated through CODEP's supervisory structure, with USDA phytosanitary certification and origin documentation from Blue Forest Farms LLC, Colorado. No cultivar enters production without full CODEP approval and chain-of-custody documentation from seed origin through to harvest batch. All genetics are INCB treaty-compliant and meet the import specifications of target pharmaceutical markets.
Origin: Blue Forest Farms LLC, Colorado USA. HPLC verified: CBDA 14.864%, CBD 1.699%, Max THC 0.30%. Feminised seed stock. Core export cultivar.
Heritage African landrace cultivar adapted for DRC equatorial conditions. High yield per cycle. Supplied to licensed pharmaceutical markets under CODEP export authorisation.
Portfolio of additional certified USA-origin genetics, selected for pharmaceutical-grade cannabinoid profiles. Full phytosanitary documentation available for all imported cultivars.
Dried flower, hemp fibre, essential oils, and cannabinoid derivatives processed under CODEP authorisation. Available in export-ready pharmaceutical packaging to buyer specifications.
CongoMedicPlants operates with a total workforce of 100 people — one of the most substantial human capital investments of any pharmaceutical cannabis producer in Central Africa. This team is not assembled casually: it is structured, trained, credentialed, and continuously developed to meet the exacting standards of pharmaceutical-grade cannabis production and international export compliance.
Every department — from cultivation and quality control to security and finance — operates under defined protocols, with clear lines of accountability running from field operative level through to the Managing Director and CODEP's own regulatory oversight structure. The result is an operation that investors and pharmaceutical buyers can audit with confidence.
The strength of CongoMedicPlants is inseparable from the quality of its people. With 100 personnel deployed across every operational function, the farm maintains one of the most professionally structured workforces in Central Africa's pharmaceutical cannabis sector — supported by state-level security oversight, CODEP-credentialed quality officers, and internationally experienced financial and strategic advisors.
Professor John Kasuku directs the operations of CongoMedicPlants with a combination of doctoral-level scientific rigour and deep, on-the-ground operational experience in African pharmaceutical cannabis production. Holding a doctorate from Coventry University, United Kingdom, Professor Kasuku brings internationally validated expertise in agricultural science, regulatory compliance, and pharmaceutical-grade production standards to a farm that he has built from the ground up into one of Africa's most significant medical cannabis operations.
In his concurrent role as Deputy Managing Director of CODEP Sarl — the DRC's government-mandated Cannabis sativa regulatory authority — Professor Kasuku uniquely bridges CongoMedicPlants' ground-level operational expertise with the highest level of national regulatory authority. His oversight of pharmaceutical-grade cultivation, international trade compliance, export documentation, and producer relations across CODEP's 380+ member network places CongoMedicPlants at the centre of the DRC's national cannabis sector — not merely as a participant, but as a founding and defining institution.
Professor Kasuku's international profile extends beyond the DRC: actively engaged in the African medical cannabis sector since 2020, overseeing operations spanning 200 hectares across the continent, and leading agricultural investment and funding strategies with a combined target value of US$2 billion across four African countries. This global network and financial expertise is brought directly to bear on CongoMedicPlants' buyer relationships, investor engagements, and international market development.
Leads the farm's complete agronomic programme across all cultivation zones — outdoor fields, greenhouse complexes, and indoor environments. Responsible for planting schedules, soil science, irrigation management, organic pest control, canopy supervision, and harvest timing across all four annual production cycles. All cultivation protocols are aligned with CODEP's Good Agricultural and Collection Practices (GACP) framework and are subject to regular inspection by CODEP's QC Officers.
📷 Profile photograph to be inserted — 128×128px
Manages all internal compliance functions — batch documentation, chain-of-custody records, inventory reconciliation, CODEP audit liaison, ACOREP pharmaceutical regulatory reporting, and pre-export quality verification. Coordinates directly with CongoMedicPlants' three rotating CODEP-accredited QC Officers to ensure every production batch is independently verified before release. Every export consignment leaves the farm accompanied by a complete, CODEP-endorsed compliance dossier.
📷 Profile photograph to be inserted — 128×128px
Commands the 20-person military-grade security detachment responsible for perimeter protection, controlled access management, CCTV surveillance oversight, patrol scheduling, and incident response across all CongoMedicPlants facilities. Security protocols are designed to meet both the physical security requirements of international pharmaceutical regulatory bodies and the national oversight standards mandated by the DRC's ANR (Economic and Financial Intelligence Department). All security operations are formally reported within CODEP's compliance framework.
📷 Profile photograph to be inserted — 128×128px
Godfred Frimpong serves CongoMedicPlants as an independent strategic advisor across three critical dimensions: financial audit, operational governance, and security assurance — bringing an exceptional combination of international professional credentials and deep sector expertise that few advisors on the continent can match.
As a Fellow Chartered Accountant (FCCA) and holder of an MSc in Food Economics & Marketing, Mr Frimpong conducts independent audits of CongoMedicPlants' financial records, operational procedures, and security frameworks — providing the management team, CODEP, and international investors with the assurance of external, professionally qualified verification. His work ensures that CongoMedicPlants' financial reporting and operational claims meet the standard expected by institutional pharmaceutical buyers and sovereign-level investors.
"The appointment of Godfred Frimpong as Strategic Advisor represents CongoMedicPlants' commitment to the highest level of independent external oversight — covering not just financial performance, but the operational and security standards that international pharmaceutical buyers require before committing to long-term supply relationships."
All international exports from CongoMedicPlants are executed exclusively through CODEP Sarl — the DRC's single point of export compliance — ensuring full regulatory documentation, narcotics import/export authorisation, and treaty-compliant delivery for every shipment.
Through CODEP Sarl, CongoMedicPlants has access to a global network of regulatory, scientific, and commercial partners — providing compliance coverage across every target export market.
100% organic inputs throughout the production cycle. No synthetic chemicals, pesticides, or hormones. Water management practices designed to protect local ecosystems. Soil health maintained through regenerative agricultural techniques across all cultivation zones.
CongoMedicPlants directly employs 100 people — 35 full-time and 45 part-time — creating meaningful, sustained employment for Congolese workers at every skill level. From military-grade security personnel and CODEP-accredited QC officers to field agronomists and trained medics, the farm's workforce reflects a commitment to both pharmaceutical-grade operational excellence and genuine local economic development — fully aligned with CODEP's national mission.
Fully compliant with DRC corporate law under OHADA commercial statute. Institutional oversight by CODEP, ACOREP, CMPC, and the ANR. Complete audit trail from seed procurement to export delivery. All documentation available to qualified buyers under NDA for due diligence review.
Buyers, pharmaceutical partners, offtake partners, and export partners must contact CODEP directly. CODEP controls the approval route, export documentation, quality review, buyer due diligence, and regulatory interface.
Investors may contact CongoMedicPlants for initial commercial discussions. Any formal partnership, farm investment, planting programme, or export-linked investment must then proceed through CODEP for the required approvals and authorisations.
Buyers and export partners must contact CODEP directly. CongoMedicPlants may handle initial investor discussions, but CODEP remains the approval, planting supervision, seed procurement, compliance, and export authority.